Friday 31 December 2021
Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation patients Treated by TAVR
Laurent DIETRICH
Post-procedural CT-ADP > 180 s in anticoagulated AF patients after TAVR strongly predicts late major/life-threatening bleeding complications (MLBCs). Persistent primary hemostasis disorders contribute to increased bleeding risk and should guide personalized anticoagulation therapy.
Un CT-ADP > 180 s après TAVR chez les patients anticoagulés et ayant une fibrillation atriale prédit fortement les saignements graves tardifs. Les troubles persistants de l'hémostase primaire augmentent le risque de saignements et doivent guider une thérapie anticoagulante personnalisée.